A detailed history of Xtx Topco LTD transactions in Atossa Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 49,616 shares of ATOS stock, worth $64,004. This represents 0.01% of its overall portfolio holdings.

Number of Shares
49,616
Previous 24,665 101.16%
Holding current value
$64,004
Previous $29,000 158.62%
% of portfolio
0.01%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.09 - $1.52 $27,196 - $37,925
24,951 Added 101.16%
49,616 $75,000
Q2 2024

Aug 12, 2024

BUY
$1.03 - $2.1 $25,404 - $51,796
24,665 New
24,665 $29,000
Q4 2023

Feb 13, 2024

SELL
$0.63 - $0.98 $51,696 - $80,416
-82,058 Reduced 49.01%
85,369 $75,000
Q3 2023

Nov 13, 2023

BUY
$0.74 - $1.35 $94,752 - $172,859
128,044 Added 325.13%
167,427 $123,000
Q2 2023

Aug 14, 2023

BUY
$0.6 - $1.28 $23,629 - $50,410
39,383 New
39,383 $49,000
Q1 2022

May 13, 2022

SELL
$1.11 - $1.74 $19,175 - $30,058
-17,275 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$1.6 - $3.27 $27,640 - $56,489
17,275 New
17,275 $28,000
Q2 2021

Aug 12, 2021

SELL
$1.52 - $8.62 $30,995 - $175,779
-20,392 Closed
0 $0
Q1 2021

May 14, 2021

BUY
$0.92 - $4.33 $18,760 - $88,297
20,392 New
20,392 $43,000

About ATOSSA THERAPEUTICS, INC.


  • Ticker ATOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,624,000
  • Market Cap $163M
  • Description
  • Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...
More about ATOS
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.